ORAPRED ODT

PREDNISOLONE SODIUM PHOSPHATE · Advanz Pharma (US) Corp.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ORAPRED ODT, covering 2006-06-01 to 2024-06-05. Get the full timeline:

Most recent: FDA Approved: ORAPRED ODT — Supplemental Application (Advanz Pharma (US) Corp.)